IL-19's role in improving lymphatic function during high cholesterol levels
IL-19 Modifies Lymphatic Flux During Hyperlipidemia
This study is looking at how a protein called IL-19 influences the lymphatic system and inflammation related to heart disease, with the hope that improving lymphatic function could help reduce harmful plaque in arteries, which might lead to new treatments for better heart health.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Temple Univ of the Commonwealth NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project ID | NIH-10825817 on NIH RePORTER |
What this research studies
This research investigates how IL-19, a cytokine, affects lymphatic function and inflammation in the context of atherosclerosis, a major cardiovascular disease. By exploring the relationship between lymphatic vessels and cholesterol transport, the study aims to understand how enhancing lymphatic function could help reduce plaque buildup in arteries. Patients may benefit from insights into new therapeutic approaches that target inflammation and lymphatic health to improve cardiovascular outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals at risk for cardiovascular diseases, particularly those with high cholesterol or atherosclerosis.
Not a fit: Patients with non-cardiovascular related conditions or those not experiencing issues related to cholesterol or atherosclerosis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that effectively reduce atherosclerosis and improve heart health.
How similar studies have performed: Previous research has shown promising results in targeting inflammation and lymphatic function in cardiovascular diseases, suggesting potential for success in this approach.
Where this research is happening
Philadelphia, United States
- Temple Univ of the Commonwealth — Philadelphia, United States (Active)
Researchers
- Principal investigator: Peluzzo, Amanda — Temple Univ of the Commonwealth
- Study coordinator: Peluzzo, Amanda
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.